Letter Sequence Approval |
|---|
EPID:L-2018-LLM-0154, Shine Medical Technologies, Inc., Submittal of Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 (Approved, Closed) |
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance...
|
MONTHYEARML16238A0342016-08-25025 August 2016
Shine Medical Technologies, Inc., Submittal of Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001
Project stage: Request
ML17055A5732017-02-24024 February 2017
Shine Medical Technologies, Inc. - Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001
Project stage: Request
ML17235A1102017-08-23023 August 2017
Shine Medical Technologies, Inc. - Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001
Project stage: Request
ML18054A0022018-02-23023 February 2018
Shine Medical Technologies - Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001
Project stage: Request
ML18166A1782018-06-13013 June 2018
Shine Medical Technologies, Inc., Submittal of Annual Financial Report
Project stage: Request
ML18234A0202018-08-22022 August 2018
Shine Medical Technologies, Inc. - Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001
Project stage: Request
ML18347A2152018-12-11011 December 2018
Shine Medical Technologies - Application for Order Approving Indirect Transfer of Control of Construction Permit and Conforming Administrative Construction Permit Amendment
Project stage: Request
ML19024A5302019-02-13013 February 2019
Shine Medical Technologies, Inc. - Request for Additional Information Regarding the Application for Indirect License Transfer and Conforming Amendment
Project stage: RAI
ML19010A1722019-02-13013 February 2019
Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure
Project stage: Withholding Request Acceptance
ML19010A0952019-02-13013 February 2019, 14 February 2019
Shine Medical Technologies, Inc. Application for Indirect License Transfer
Project stage: Request
ML19010A0962019-02-13013 February 2019
Shine Medical Technologies, Inc. - Notice of Consideration of Approval of Indirect License Transfer and Conforming Amendment and Opportunity for a Hearing and Petition for Leave to Intervene
Project stage: Other
ML19010A0972019-02-14014 February 2019
Shine Medical Technologies, Inc. - Federal Register Notice Related to Consideration of Approval of Transfer of License and Conforming Amendment
Project stage: Other
ML19053A2782019-02-22022 February 2019
Shine Medical Technologies - Periodic Report Required by the License Conditions in Section 3.0.(1) of CPMIF-001
Project stage: Request
ML19071A0562019-03-0808 March 2019
Shine Medical Technologies, Inc., Affidavit & Response to Request for Additional Information to Application for Order Approving Indirect Transfer of Control of Construction Permit Response to Request for Additional Information
Project stage: Response to RAI
ML19071A0552019-03-0808 March 2019
Shine Medical Technologies, Inc., Application for Order Approving Indirect Transfer of Control of Construction Permit Response to Request for Additional Information
Project stage: Response to RAI
ML19102A3482019-05-0202 May 2019
Shine Medical Technologies, Inc. - Response to Withholding Request Related to Indirect Transfer of and Conforming Amendment to Construction Permit No. CPMIF-001
Project stage: Other
ML19102A3212019-05-0202 May 2019, 20 May 2019, 30 May 2019
Shine Medical Technologies, Inc. - Indirect Transfer of and Conforming Amendment to Construction Permit No. CPMIF-001
Project stage: Request
ML19102A3242019-05-20020 May 2019
Shine Medical Technologies, Inc. - Order Approving Indirect Transfer of and Conforming Amendment to Construction Permit No. CPMIF-001
Project stage: Request
ML19102A3232019-05-20020 May 2019
Shine Medical Technologies, Inc. - Cover Letter for Indirect Transfer of and Conforming Amendment to Construction Permit No. CPMIF-001
Project stage: Other
ML19162A0262019-07-0101 July 2019
Shine Medical Technologies, LLC - Amendment No. 1 to Shine Medical Isotope Production Facility Construction Permit No. CPMIF-001
Project stage: Other
ML19162A0242019-07-0101 July 2019
Shine Medical Technologies, LLC - Issuance of Amendment Reflecting Indirect Transfer of Construction Permit No. CPMIF-001
Project stage: Request
ML19162A0252019-07-0101 July 2019
Shine Medical Technologies, LLC - Issuance of Amendment Reflecting Indirect Transfer of Construction Permit No. CPMIF-001
Project stage: Approval
ML19234A0472019-08-22022 August 2019
Shine Medical Technologies - Periodic Report Required by the License Conditions in Section 3.0.(1) of CPMIF-001
Project stage: Request
ML19331A8322019-11-14014 November 2019
Shine Medical Technologies, LLC Supplement 1 to Final Safety Analysis Report
Project stage: Request
ML20052C7942020-02-21021 February 2020
Shine Medical Technologies, Inc., Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001
Project stage: Other
2019-02-13
[Table View] |
Text
July 1, 2019 Gregory Piefer, Ph.D.
Chief Executive Officer SHINE Medical Technologies, LLC 101 E. Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, LLC - ISSUANCE OF AMENDMENT REFLECTING INDIRECT TRANSFER OF CONSTRUCTION PERMIT NO. CPMIF-001 (EPID NO. L-2018-LLM-0154)
Dear Dr. Piefer:
By order dated May 20, 2019 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML19102A324), the U.S. Nuclear Regulatory Commission (NRC or the Commission) approved the indirect transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility, previously held by SHINE Medical Technologies, Inc. (SHINE). The indirect transfer is the result of the establishment of a holding company, Illuminated Holdings, Inc. (Illuminated). To facilitate this transfer, SHINE requested NRC approval of a conforming amendment to the construction permit in an application dated December 11, 2018 (ADAMS Accession No. ML18347A215), as supplemented by letter dated March 8, 2019 (ADAMS Accession No. ML19071A055). The amendment modifies Construction Permit No. CPMIF-001 to reflect that the transfer results in SHINE converting from a corporation into a single-member limited liability company, SHINE Medical Technologies, LLC (SHINE LLC),
owned and controlled by Illuminated.
Accordingly, the Commission has issued the enclosed Amendment No. 1 to Construction Permit No. CPMIF-001 for SHINE LLC.
A copy of the related safety evaluation was enclosed with the letter dated May 20, 2019. A Notice of Issuance will be included in the Commissions biweekly Federal Register notice.
If you have any questions, please contact me at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov.
Sincerely,
/RA/
Steven Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-608 Construction Permit No. CPMIF-001
Enclosure:
As stated cc: w/enclosure: See next page
SHINE Medical Technologies, LLC Docket No. 50-608 cc:
Jeff Bartelme Licensing Manager SHINE Medical Technologies, LLC 101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 Christopher Landers Director, Office of Conversion National Nuclear Security Administration, NA-23 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585 Mark Paulson Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 Test, Research and Training Reactor Newsletter Attention: Amber Johnson Dept of Materials Science and Engineering University of Maryland 4418 Stadium Dr.
College Park, MD 20742-2115 Mark Freitag City Manager P.O. Box 5005 Janesville, WI 53547-5005 Bill McCoy 1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich 541 Miller Avenue Janesville, WI 53548
ML19162A025 (Letter);
ML19162A026 (Amendment);
ML19162A024 (Package)
- concurred via e-mail OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/LA*
OGC*
NRR/DLP/PRLB/BC NAME SLynch NParker JWachutka GCasto CMontgomery(for)
DATE 6/13/2019 6/13/2019 5/26/2019 6/14/2019 OFFICE NRR/DLP/DDD NRR/DLP/PRLB/PM NAME TLaLain SLynch DATE 6/17/2019 6/25/2019